{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:13:34Z","timestamp":1790993614554,"version":"4.1.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,1,18]],"date-time":"2016-01-18T00:00:00Z","timestamp":1453075200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s00105-015-3751-5","type":"journal-article","created":{"date-parts":[[2016,1,18]],"date-time":"2016-01-18T08:59:44Z","timestamp":1453107584000},"page":"173-189","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Vitiligo"],"prefix":"10.1007","volume":"67","author":[{"given":"M.","family":"Schild","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Meurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,18]]},"reference":[{"key":"3751_CR1","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1365-4632.2007.03195.x","volume":"46","author":"GW Millington","year":"2007","unstructured":"Millington GW, Levell NJ (2007) Vitiligo: the historical course of depigmentation. Int J Dermatol 46:990\u2013995","journal-title":"Int J Dermatol"},{"key":"3751_CR2","first-page":"703","volume-title":"Pathologie und Therapie der Hautkrankheiten in Vorlesungen f\u00fcr praktische \u00c4rzte und Studierende","author":"M Kaposi","year":"1899","unstructured":"Kaposi M (1899) Pathologie und Therapie der Hautkrankheiten. In : Vorlesungen f\u00fcr praktische \u00c4rzte und Studierende, 5.\u00a0Aufl. Urban und Schwarzenberg, Berlin, S\u00a0703\u2013707","edition":"5"},{"key":"3751_CR3","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/j.1365-4632.2011.05377.x","volume":"51","author":"C Kr\u00fcger","year":"2012","unstructured":"Kr\u00fcger C, Schallreuter KU (2012) A review of the worldwide prevalence of vitiligo in children\/adolescents and adults. Int J Dermatol 51:1206\u20131212","journal-title":"Int J Dermatol"},{"key":"3751_CR4","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2133.2011.10650.x","volume":"166","author":"N Geel Van","year":"2012","unstructured":"Van Geel N, Mollet I, Brochez L et al (2012) New insights in segmental vitiligo: case report and review of theories. Br J Dermatol 166:240\u2013246","journal-title":"Br J Dermatol"},{"key":"3751_CR5","first-page":"167","volume-title":"Pigmentary disorders: a comprehensive compendium","author":"S Dhar","year":"2014","unstructured":"Dhar S, Banerjee R, Malakar R (2014) Vitiligo in Children. In: Lahiri K, Chatterjee M, Sarkar R (Hrsg) Pigmentary disorders: a comprehensive compendium. Jaypee Brothers Medical Publishers (P) Ltd, New Delhi, S\u00a0167\u2013179"},{"key":"3751_CR6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-0749.2006.00355.x","volume":"20","author":"A Ta\u00efeb","year":"2007","unstructured":"Ta\u00efeb A, Picardo M, VETF Members (2007) The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res 20:27\u201335","journal-title":"Pigment Cell Res"},{"key":"3751_CR7","doi-asserted-by":"crossref","unstructured":"Ezzedine K, Lim HW, Suzuki T et al (2012) Revised classification\/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference. Pigment Cell Melanoma Res 25:E1\u2013E13","DOI":"10.1111\/j.1755-148X.2012.00997.x"},{"key":"3751_CR8","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jaad.2015.05.038","volume":"73","author":"EW Mu","year":"2015","unstructured":"Mu EW, Cohen BE, Orlow SJ (2015) Early-onset childhood vitiligo is associated with a more extensive and progressive course. J Am Acad Dermatol 73:467\u2013470","journal-title":"J Am Acad Dermatol"},{"key":"3751_CR9","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1111\/j.1468-3083.2012.04504.x","volume":"27","author":"A Patrizi","year":"2013","unstructured":"Patrizi A, Bentivogli M, Raone B et al (2013) Association of halo nevus and vitiligo in childhood: a retrospective observational study. J Eur Acad Dermatol Venereol 27:e148\u2013e152","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3751_CR10","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/archdermatol.2011.351","volume":"148","author":"K Ezzedine","year":"2012","unstructured":"Ezzedine K, Diallo A, L\u00e9aut\u00e9-Labr\u00e8ze C et al (2012) Halo nevi association in nonsegmental vitiligo affects age at onset and depigmentation pattern. Arch Dermatol 148:497\u2013502","journal-title":"Arch Dermatol"},{"key":"3751_CR11","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1365-2133.2011.10709.x","volume":"166","author":"K Ezzedine","year":"2012","unstructured":"Ezzedine K, Diallo A, L\u00e9aut\u00e9-Labr\u00e8ze C et al (2012) Halo naevi and leukotrichia are strong predictors of the passage to mixed vitiligo in a subgroup of segmental vitiligo. Br J Dermatol 166:539\u2013544","journal-title":"Br J Dermatol"},{"key":"3751_CR12","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/jdv.12573","volume":"29","author":"I Seleit","year":"2015","unstructured":"Seleit I, Bakry OA, Abdou AG, Dawoud NM (2015) Immunohistochemical evaluation of vitiliginous hair follicle melanocyte reservoir: is it retained? J Eur Acad Dermatol Venereol 29:444\u2013451","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3751_CR13","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1365-2133.2012.11111.x","volume":"167","author":"N Geel Van","year":"2012","unstructured":"Van Geel N, Speeckaert R, De Wolf J et al (2012) Clinical significance of Koebner phenomenon in vitiligo. Br J Dermatol 167:1017\u20131024","journal-title":"Br J Dermatol"},{"key":"3751_CR14","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0190-9622(96)90718-5","volume":"35","author":"SK Hann","year":"1996","unstructured":"Hann SK, Lee HJ (1996) Segmental vitiligo: clinical findings in 208 patients. J Am Acad Dermatol 35:671\u2013674","journal-title":"J Am Acad Dermatol"},{"key":"3751_CR15","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1034\/j.1600-0749.2003.00032.x","volume":"16","author":"A Alkhateeb","year":"2003","unstructured":"Alkhateeb A, Fain PR, Thody A et al(2003) Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res 16:208\u2013214","journal-title":"Pigment Cell Res"},{"key":"3751_CR16","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2332\/allergolint.11-OA-0303","volume":"60","author":"T Narita","year":"2011","unstructured":"Narita T, Oiso N, Fukai K et al (2011) Generalized vitiligo and associated autoimmune diseases in Japanese patients and their families. Allergol Int 60:505\u2013508","journal-title":"Allergol Int"},{"key":"3751_CR17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-4632.2010.04665.x","volume":"50","author":"S Uncu","year":"2011","unstructured":"Uncu S, Yayl\u0131 S, Bahad\u0131r S et al (2011) Relevance of autoimmune thyroiditis in children and adolescents with vitiligo. Int J Dermatol 50:175\u2013179","journal-title":"Int J Dermatol"},{"key":"3751_CR18","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1089\/thy.2010.1643","volume":"20","author":"RA Spritz","year":"2010","unstructured":"Spritz RA (2010) Shared genetic relationships underlying generalized vitiligo and autoimmune thyroid disease. Thyroid 20:745\u2013754","journal-title":"Thyroid"},{"key":"3751_CR19","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000354607","volume":"227","author":"VM Sheth","year":"2013","unstructured":"Sheth VM, Guo Y, Qureshi AA (2013) Comorbidities associated with vitiligo: a ten-year retrospective study. Dermatology 227:311\u2013315","journal-title":"Dermatology"},{"key":"3751_CR20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/978-3-540-69361-1_11","volume-title":"Vitiligo","author":"I Mollet","year":"2010","unstructured":"Mollet I, Van Geel N, Lambert J (2010) Autoimmune\/inflammatory and other diseases associated with vitiligo. In: Picardo M, Taieb A (Hrsg) Vitiligo. Springer-Verlag, Berlin, S\u00a079\u201390"},{"key":"3751_CR21","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0140-6736(14)60763-7","volume":"386","author":"K Ezzedine","year":"2015","unstructured":"Ezzedine K, Eleftheriadou V, Whitton M, van Geel N (2015) Vitiligo. Lancet 386:74\u201384","journal-title":"Lancet"},{"key":"3751_CR22","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1684\/ejd.2009.0939","volume":"20","author":"P Amerio","year":"2010","unstructured":"Amerio P, Di Rollo D, Carbone A et al (2010) Polyglandular autoimmune diseases in a dermatological clinical setting: vitiligo-associated autoimmune diseases. Eur J Dermatol 20:354\u2013358","journal-title":"Eur J Dermatol"},{"key":"3751_CR23","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1111\/jdv.12870","volume":"29","author":"YT Chen","year":"2015","unstructured":"Chen YT, Chen YJ, Hwang CY et al (2015) Comorbidity profiles in association with vitiligo: a nationwide population-based study in Taiwan. J Eur Acad Dermatol Venereol 29:1362\u20131369","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3751_CR24","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1365-2230.1998.00384.x","volume":"23","author":"L Papadopoulos","year":"1998","unstructured":"Papadopoulos L, Bor R, Legg C, Hawk JL (1998) Impact of life events on the onset of vitiligo in adults: preliminary evidence for a psychological dimension in aetiology. Clin Exp Dermatol 23:243\u2013248","journal-title":"Clin Exp Dermatol"},{"key":"3751_CR25","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/bjd.12162","volume":"168","author":"C Vrijman","year":"2013","unstructured":"Vrijman C, Hosseinpour D, Bakker JG et al (2013) Provoking factors, including chemicals, in Dutch patients with vitiligo. Br J Dermatol 168:1003\u20131011","journal-title":"Br J Dermatol"},{"key":"3751_CR26","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s00105-009-1916-9","volume":"61","author":"KU Schallreuter","year":"2010","unstructured":"Schallreuter KU, Salem MM (2010) [Vitiligo. What is new?]. Hautarzt 61:578\u2013585","journal-title":"Hautarzt"},{"key":"3751_CR27","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4103\/0019-5154.152508","volume":"60","author":"LN Sangma","year":"2015","unstructured":"Sangma LN, Nath J, Bhagabati D (2015) Quality of life and psychological morbidity in vitiligo patients: a study in a teaching hospital from north-East India. Indian J Dermatol 60:142\u2013146","journal-title":"Indian J Dermatol"},{"key":"3751_CR28","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2133.2012.11197.x","volume":"168","author":"A Taieb","year":"2013","unstructured":"Taieb A, Alomar A, B\u00f6hm M et al (2013) Guidelines for the management of vitiligo: the European Dermatology Forum consensus. Br J Dermatol 168:5\u201319","journal-title":"Br J Dermatol"},{"key":"3751_CR29","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.det.2011.11.013","volume":"30","author":"SS Bhandarkar","year":"2012","unstructured":"Bhandarkar SS, Kundu RV (2012) Quality-of-life issues in vitiligo. Dermatol Clin 30:255\u2013268","journal-title":"Dermatol Clin"},{"key":"3751_CR30","doi-asserted-by":"crossref","first-page":"446","DOI":"10.2340\/00015555-1520","volume":"93","author":"M Karelson","year":"2013","unstructured":"Karelson M, Silm H, Kingo K (2013) Quality of life and emotional state in vitiligo in an Estonian sample: comparison with psoriasis and healthy controls. Acta Derm Venereol 93:446\u2013450","journal-title":"Acta Derm Venereol"},{"key":"3751_CR31","doi-asserted-by":"crossref","unstructured":"B\u00f6hm M (2015) Differenzialdiagnostik der Hypomelanosen. Hautarzt 66:945\u2013960","DOI":"10.1007\/s00105-015-3717-7"},{"key":"3751_CR32","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1610-0387.2009.07137_supp.x","volume":"8","author":"SK Fistarol","year":"2010","unstructured":"Fistarol SK, Itin PH (2010) Disorders of Pigmentation. J Dtsch Dermatol Ges 8:187\u2013203","journal-title":"J Dtsch Dermatol Ges"},{"key":"3751_CR33","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1600-0749.2004.00130.x","volume":"17","author":"RE Boissy","year":"2004","unstructured":"Boissy RE, Manga P (2004) On the etiology of contact\/occupational vitiligo. Pigment Cell Res 17:208\u2013214","journal-title":"Pigment Cell Res"},{"key":"3751_CR34","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jaad.2014.07.050","volume":"71","author":"A Paradisi","year":"2014","unstructured":"Paradisi A, Tabolli S, Didona B et al (2014) Markedly reduced incidence of melanoma and nonmelanoma skin cancer in a nonconcurrent cohort of 10,040 patients with vitiligo. J Am Acad Dermatol 71:1110\u20131116","journal-title":"J Am Acad Dermatol"},{"key":"3751_CR35","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1001\/archderm.1995.01690150078015","volume":"131","author":"J Cui","year":"1995","unstructured":"Cui J, Bystryn JC (1995) Melanoma and vitiligo are associated with antibody responses to similar antigens on pigment cells. Arch Dermatol 131:314\u2013318","journal-title":"Arch Dermatol"},{"key":"3751_CR36","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ng.2272","volume":"44","author":"Y Jin","year":"2012","unstructured":"Jin Y, Birlea SA, Fain PR et al (2012) Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo. Nat Genet 44:676\u2013680","journal-title":"Nat Genet"},{"key":"3751_CR37","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/archderm.1987.01660320095019","volume":"123","author":"JC Bystryn","year":"1987","unstructured":"Bystryn JC, Rigel D, Friedman RJ, Kopf A (1987) Prognostic significance of hypopigmentation in malignant melanoma. Arch Dermatol 123:1053\u20131055","journal-title":"Arch Dermatol"},{"key":"3751_CR38","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000247693","volume":"183","author":"KU Schallreuter","year":"1991","unstructured":"Schallreuter KU, Levenig C, Berger J (1991) Vitiligo and cutaneous melanoma. A case study. Dermatologica 183:239\u2013245","journal-title":"Dermatologica"},{"key":"3751_CR39","first-page":"1","volume":"21","author":"C Hua","year":"2015","unstructured":"Hua C, Boussemart L, Mateus C et al (2015) Association of vitiligo with tumor response in patients with metastatic melanoma treated with pembrolizumab. JAMA Dermatol 21:1\u20137","journal-title":"JAMA Dermatol"},{"key":"3751_CR40","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/bjd.12111","volume":"168","author":"HE Teulings","year":"2013","unstructured":"Teulings HE, Overkamp M, Ceylan E et al (2013) Decreased risk of melanoma and nonmelanoma skin cancer in patients with vitiligo: a survey among 1307 patients and their partners. Br J Dermatol 168:162\u2013171","journal-title":"Br J Dermatol"},{"key":"3751_CR41","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000057881","volume":"204","author":"KU Schallreuter","year":"2002","unstructured":"Schallreuter KU, Tobin DJ, Panske A (2002) Decreased photodamage and low incidence of non-melanoma skin cancer in 136 sun-exposed caucasian patients with vitiligo. Dermatology 204:194\u2013201","journal-title":"Dermatology"},{"key":"3751_CR42","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1096\/fj.09-132621","volume":"23","author":"MM Salem","year":"2009","unstructured":"Salem MM, Shalbaf M, Gibbons NC et al(2009) Enhanced DNA binding capacity on up-regulated epidermal wild-type p53 in vitiligo by H2O2-mediated oxidation: a possible repair mechanism for DNA damage. FASEB J 23:3790\u20133807","journal-title":"FASEB J"},{"key":"3751_CR43","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00403-011-1165-5","volume":"303","author":"A Feily","year":"2011","unstructured":"Feily A, Pazyar N (2011) Why vitiligo is associated with fewer risk of skin cancer?: providing a molecular mechanism. Arch Dermatol Res 303:623\u2013624","journal-title":"Arch Dermatol Res"},{"key":"3751_CR44","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.jaad.2008.09.033","volume":"60","author":"CL Hexsel","year":"2009","unstructured":"Hexsel CL, Eide MJ, Johnson CC et al(2009) Incidence of nonmelanoma skin cancer in a cohort of patients with vitiligo. J Am Acad Dermatol 60:929\u2013933","journal-title":"J Am Acad Dermatol"},{"key":"3751_CR45","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/bjd.13432","volume":"172","author":"L Komen","year":"2015","unstructured":"Komen L, da Gra\u00e7a V, Wolkerstorfer A et al(2015) Vitiligo Area Scoring Index and Vitiligo European Task Force assessment: reliable and responsive instruments to measure the degree of depigmentation in vitiligo. Br J Dermatol 172:437\u2013443","journal-title":"Br J Dermatol"},{"key":"3751_CR46","first-page":"79","volume-title":"Vitiligo","author":"A Taieb","year":"2010","unstructured":"Taieb A, Picardo M (2010) Evaluation, assessment and scoring. In: Picardo M, Taieb A (Hrsg) Vitiligo. Springer-Verlag, Berlin, S\u00a079\u201390"},{"key":"3751_CR47","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0925-4439(94)90027-2","volume":"1226","author":"KU Schallreuter","year":"1994","unstructured":"Schallreuter KU, Wood JM, Ziegler I et al (1994) Defective tetrahydrobiopterin and catecholamine biosynthesis in the depigmentation disorder vitiligo. Biochim Biophys Acta 1226:181\u2013192","journal-title":"Biochim Biophys Acta"},{"key":"3751_CR48","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4103\/2229-5178.96705","volume":"3","author":"DS Shankar","year":"2012","unstructured":"Shankar DS, Shashikala K, Madala R (2012) Clinical patterns of vitiligo and its associated co morbidities: a prospective controlled cross-sectional study in South India. Indian Dermatol Online J 3:114\u2013118","journal-title":"Indian Dermatol Online J"},{"key":"3751_CR49","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1590\/abd1806-4841.20142717","volume":"89","author":"AR Faria","year":"2014","unstructured":"Faria AR, Tarl\u00e9 RG, Dellatorre G et al (2014) Vitiligo \u2013 Part 2 \u2013 classification, histopathology and treatment. An Bras Dermatol 89:784\u2013790","journal-title":"An Bras Dermatol"},{"key":"3751_CR50","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3892\/mmr.2012.1117","volume":"7","author":"J Wu","year":"2013","unstructured":"Wu J, Zhou M, Wan Y, Xu A (2013) CD8+ T cells from vitiligo perilesional margins induce autologous melanocyte apoptosis. Mol Med Rep 7:237\u2013241","journal-title":"Mol Med Rep"},{"key":"3751_CR51","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH659>3.0.CO;2-D","volume":"191","author":"DJ Tobin","year":"2000","unstructured":"Tobin DJ, Swanson NN, Pittelkow MR et al(2000) Melanocytes are not absent in lesional skin of long duration vitiligo. J Pathol 191:407\u2013416","journal-title":"J Pathol"},{"key":"3751_CR52","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/1346-8138.12147","volume":"40","author":"RA Spritz","year":"2013","unstructured":"Spritz RA (2013) Modern vitiligo genetics sheds new light on an ancient disease. J Dermatol 40:310\u2013318. doi: 10.1111\/1346-8138.12147","journal-title":"J Dermatol"},{"key":"3751_CR53","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/gm199","volume":"19","author":"RA Spritz","year":"2010","unstructured":"Spritz RA (2010) The genetics of generalized vitiligo: autoimmune pathways and an inverse relationship with malignant melanoma. Genome Med 19:78","journal-title":"Genome Med"},{"key":"3751_CR54","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2133.1988.tb01778.x","volume":"118","author":"M Koga","year":"1988","unstructured":"Koga M, Tango T (1988) Clinical features and course of type A and type B vitiligo. Br J Dermatol 118:223\u2013228","journal-title":"Br J Dermatol"},{"key":"3751_CR55","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0923-1811(99)00090-0","volume":"23","author":"CS Wu","year":"2000","unstructured":"Wu CS, Yu HS, Chang HR et al(2000) Cutaneous blood flow and adrenoceptor response increase in segmental-type vitiligo lesions. J Dermatol Sci 23:53\u201362","journal-title":"J Dermatol Sci"},{"key":"3751_CR56","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1076\/1381345520000710831ZFT262","volume":"108","author":"R Lazarova","year":"2000","unstructured":"Lazarova R, Hristakieva E, Lazarov N, Shani J (2000) Vitiligo-related neuropeptides in nerve fibers of the skin. Arch Physiol Biochem 108:262\u2013267","journal-title":"Arch Physiol Biochem"},{"key":"3751_CR57","doi-asserted-by":"crossref","first-page":"e107020","DOI":"10.1371\/journal.pone.0107020","volume":"9","author":"NC Laddha","year":"2014","unstructured":"Laddha NC, Dwivedi M, Mansuri MS et al (2014) Association of neuropeptide Y (NPY), interleukin-1B (IL1B) genetic variants and correlation of IL1B transcript levels with vitiligo susceptibility. PLoS One 9:e107020","journal-title":"PLoS One"},{"key":"3751_CR58","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.autrev.2014.12.003","volume":"14","author":"R Speeckaert","year":"2015","unstructured":"Speeckaert R, Speeckaert MM, van Geel N (2015) Why treatments do(n\u2019t) work in vitiligo: an autoinflammatory perspective. Autoimmun Rev 14:332\u2013340","journal-title":"Autoimmun Rev"},{"key":"3751_CR59","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1034\/j.1600-0749.2003.00023.x","volume":"16","author":"K Ongenae","year":"2003","unstructured":"Ongenae K, Van Geel N, Naeyaert JM (2003) Evidence for an autoimmune pathogenesis of vitiligo. Pigment Cell Res 16:90\u2013100","journal-title":"Pigment Cell Res"},{"key":"3751_CR60","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/jid.2011.463","volume":"132","author":"JE Harris","year":"2012","unstructured":"Harris JE, Harris TH, Weninger W et al(2012) A mouse model of vitiligo with focused epidermal depigmentation requires IFN-\u03b3 for autoreactive CD8+ T-cell accumulation in the skin. J Invest Dermatol 132:1869\u20131876","journal-title":"J Invest Dermatol"},{"key":"3751_CR61","doi-asserted-by":"crossref","first-page":"e37513","DOI":"10.1371\/journal.pone.0037513","volume":"7","author":"Y Lili","year":"2012","unstructured":"Lili Y, Yi W, Ji Y et al (2012) Global activation of CD8+ cytotoxic T lymphocytes correlates with an impairment in regulatory T cells in patients with generalized vitiligo. PLoS One 7:e37513","journal-title":"PLoS One"},{"key":"3751_CR62","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1755-148X.2011.00945.x","volume":"25","author":"Y Kotobuki","year":"2012","unstructured":"Kotobuki Y, Tanemura A, Yang L et al (2012) Dysregulation of melanocyte function by Th17-related cytokines: significance of Th17 cell infiltration in autoimmune vitiligo vulgaris. Pigment Cell Melanoma Res 25:219\u2013230","journal-title":"Pigment Cell Melanoma Res"},{"key":"3751_CR63","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1046\/j.1365-2133.2001.03952.x","volume":"144","author":"K Jimbow","year":"2001","unstructured":"Jimbow K, Chen H, Park JS, Thomas PD (2001) Increased sensitivity of melanocytes to oxidative stress and abnormal expression of tyrosinase-related protein in vitiligo. Br J Dermatol 144:55\u201365","journal-title":"Br J Dermatol"},{"key":"3751_CR64","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1468-3083.2012.04501.x","volume":"27","author":"MW Kroon","year":"2013","unstructured":"Kroon MW, Kemp EH, Wind BS et al (2013) Melanocyte antigen-specific antibodies cannot be used as markers for recent disease activity in patients with vitiligo. J Eur Acad Dermatol Venereol 27:1172\u20131175","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3751_CR65","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/1523-1747.ep12492607","volume":"97","author":"R Harning","year":"1991","unstructured":"Harning R, Cui J, Bystryn JC (1991) Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo. J Invest Dermatol 97:1078\u20131080","journal-title":"J Invest Dermatol"},{"key":"3751_CR66","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1034\/j.1600-0749.2002.1o049.x","volume":"15","author":"S Moretti","year":"2002","unstructured":"Moretti S, Spallanzani A, Amato L et al (2002) New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions. Pigment Cell Res 15:87\u201392","journal-title":"Pigment Cell Res"},{"key":"3751_CR67","doi-asserted-by":"crossref","first-page":"664","DOI":"10.2340\/00015555-2080","volume":"95","author":"L Yang","year":"2015","unstructured":"Yang L, Wei Y, Sun Y et al (2015) Interferon-gamma inhibits melanogenesis and induces apoptosis in melanocytes: a pivotal role of CD8+ cytotoxic T lymphocytes in vitiligo. Acta Derm Venereol 95:664\u2013670","journal-title":"Acta Derm Venereol"},{"key":"3751_CR68","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1684\/ejd.2013.2023","volume":"23","author":"MA Elela","year":"2013","unstructured":"Elela MA, Hegazy RA, Fawzy MM et al (2013) Interleukin 17, interleukin 22 and FoxP3 expression in tissue and serum of non-segmental vitiligo: a case- controlled study on eighty-four patients. Eur J Dermatol 23:350\u2013355","journal-title":"Eur J Dermatol"},{"key":"3751_CR69","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/pcmr.12219","volume":"27","author":"A Bertolotti","year":"2014","unstructured":"Bertolotti A, Boniface K, Vergier B et al (2014) Type I interferon signature in the initiation of the immune response in vitiligo. Pigment Cell Melanoma Res 27:398\u2013407","journal-title":"Pigment Cell Melanoma Res"},{"key":"3751_CR70","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/bjd.12691","volume":"170","author":"J Marie","year":"2014","unstructured":"Marie J, Kovacs D, Pain C et al (2014) Inflammasome activation and vitiligo\/nonsegmental vitiligo progression. Br J Dermatol 170:816\u2013823","journal-title":"Br J Dermatol"},{"key":"3751_CR71","doi-asserted-by":"crossref","first-page":"631927","DOI":"10.1155\/2015\/631927","volume":"2015","author":"R Colucci","year":"2015","unstructured":"Colucci R, Dragoni F, Moretti S (2015) Oxidative stress and immune system in vitiligo and thyroid diseases. Oxid Med Cell Longev 2015:631927","journal-title":"Oxid Med Cell Longev"},{"key":"3751_CR72","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1038\/jid.2014.65","volume":"134","author":"L Denat","year":"2014","unstructured":"Denat L, Kadekaro AL, Marrot L et al(2014) Melanocytes as instigators and victims of oxidative stress. J Invest Dermatol 134:1512\u20131518","journal-title":"J Invest Dermatol"},{"key":"3751_CR73","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.gene.2013.11.055","volume":"536","author":"U Ozel Turkcu","year":"2014","unstructured":"Ozel Turkcu U, Tekin NS, Edgunlu TG et al (2014) The association of FOXO3A gene polymorphisms with serum FOXO3A levels and oxidative stress markers in vitiligo patients. Gene 536:129\u2013134","journal-title":"Gene"},{"key":"3751_CR74","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4103\/0019-5154.57604","volume":"54","author":"R Falabella","year":"2009","unstructured":"Falabella R (2009) Vitiligo and the melanocyte reservoir. Indian J Dermatol 54:313\u2013318","journal-title":"Indian J Dermatol"},{"key":"3751_CR75","first-page":"1077","volume":"159","author":"KC Meyer","year":"2008","unstructured":"Meyer KC, Klatte JE, Dinh HV et al(2008) Evidence that the bulge region is a site of relative immune privilege in human hair follicles. Br J Dermatol 159:1077\u20131085","journal-title":"Br J Dermatol"},{"key":"3751_CR76","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1034\/j.1600-0749.2003.00070.x","volume":"16","author":"Y Gauthier","year":"2003","unstructured":"Gauthier Y, Cario Andre M, Ta\u00efeb A (2003) A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy? Pigment Cell Res 16:322\u2013332","journal-title":"Pigment Cell Res"},{"key":"3751_CR77","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/jdv.12013","volume":"27","author":"A Reichert-Faria","year":"2013","unstructured":"Reichert-Faria A, Jung JE, Moreschi Neto V et al (2013) Reduced immunohistochemical expression of Discoidin Domain Receptor 1 (DDR1) in vitiligo skin. J Eur Acad Dermatol Venereol 27:1057\u20131059","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3751_CR78","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1600-0749.2007.00396.x","volume":"20","author":"M Cario-Andr\u00e9","year":"2007","unstructured":"Cario-Andr\u00e9 M, Pain C, Gauthier Y, Ta\u00efeb A (2007) The melanocytorrhagic hypothesis of vitiligo tested on pigmented, stressed, reconstructed epidermis. Pigment Cell Res 20:385\u2013393","journal-title":"Pigment Cell Res"},{"key":"3751_CR79","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1038\/jid.2015.25","volume":"135","author":"RY Wagner","year":"2015","unstructured":"Wagner RY, Luciani F, Cario-Andr\u00e9 M et al (2015) Altered E-Cadherin levels and distribution in melanocytes precede clinical manifestations of vitiligo. J Invest Dermatol 135:1810\u20131819","journal-title":"J Invest Dermatol"},{"key":"3751_CR80","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1087-0024.2005.200407.x","volume":"10","author":"NK Haass","year":"2005","unstructured":"Haass NK, Herlyn M (2005) Normal human melanocyte homeostasis as a paradigm for understanding melanoma. J Investig Dermatol Symp Proc 10:153\u2013163","journal-title":"J Investig Dermatol Symp Proc"},{"key":"3751_CR81","doi-asserted-by":"crossref","first-page":"115","DOI":"10.5021\/ad.2012.24.2.115","volume":"24","author":"AY Lee","year":"2012","unstructured":"Lee AY (2012) Role of keratinocytes in the development of vitiligo. Ann Dermatol 24:115\u2013125","journal-title":"Ann Dermatol"},{"key":"3751_CR82","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1365-2133.1996.tb07618.x","volume":"134","author":"A Norris","year":"1996","unstructured":"Norris A, Todd C, Graham A, Quinn AG, Thody AJ (1996) The expression of the c-kit receptor by epidermal melanocytes may be reduced in vitiligo. Br J Dermatol 134:299\u2013306","journal-title":"Br J Dermatol"},{"key":"3751_CR83","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/bjd.12013","volume":"168","author":"N Geel Van","year":"2013","unstructured":"Van Geel N, Speeckaert R, Melsens E (2013) The distribution pattern of segmental vitiligo: clues for somatic mosaicism. Br J Dermatol 168:56\u201364","journal-title":"Br J Dermatol"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-015-3751-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-015-3751-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-015-3751-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T21:11:06Z","timestamp":1718313066000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-015-3751-5"}},"subtitle":["Klinik und Pathogenese","Clinical presentation and pathogenesis"],"short-title":[],"issued":{"date-parts":[[2016,1,18]]},"references-count":83,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["3751"],"URL":"https:\/\/doi.org\/10.1007\/s00105-015-3751-5","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,18]]}}}